Modulating the Endocannabinoid System in Alcohol Use Disorder: A Translational Review
Modulating endocannabinoid system alcohol use disorder is a promising area of research with significant preclinical evidence. This review synthesizes data on cannabinoid receptor modulation and its impact on alcohol consumption. Understanding these…
Cannabis Co-Use and Endocannabinoid System Modulation in Tobacco Use Disorder: A Translational Systematic Review and Meta-Analysis
Cannabis co-use tobacco cessation presents unique challenges in treating tobacco use disorder. This review highlights how cannabis use affects quit success rates. Understanding endocannabinoid system modulation is key to advancing treatment strategies.
Regular Cannabinoid Use and Inflammatory Biomarkers: A Meta-Analysis
This cannabinoids and inflammation systematic review examines inflammatory biomarkers in regular cannabinoid users. The meta-analysis synthesizes data from over 54,000 participants. Findings highlight complex associations between cannabinoid use and…
Preclinical Evidence of Cannabis-Induced Oxidative Stress: Systematic Review & Meta-Analysis
Cannabis oxidative stress markers are critical in understanding cellular damage linked to cannabis exposure. This systematic review evaluates reactive oxygen species and lipid peroxidation in preclinical models. Findings highlight oxidative stress…
Safety of Cannabidiol in Healthy Adults: A Meta-Analysis Review
This systematic review examines cbd safety in healthy adults, comparing cannabidiol to placebo. The meta-analysis highlights key adverse effects observed in non-patient populations. Understanding cbd safety in healthy adults is crucial for informed…
When Someone Asks for the Right Dose and the Answer Is It Depends #6
Personalized cannabis dosing importance is crucial because no universal dose fits all patients. Individual factors influence the optimal cannabis dose. Understanding this helps patients and clinicians approach dosing safely.
Medicare Still Ignores Cannabinoids, Seniors Still Notice #8
Senior cannabis care faces significant challenges due to Medicare's exclusion of cannabinoids. This creates access barriers for seniors seeking cannabinoid therapy. Understanding these barriers is crucial for improving senior healthcare.
When Your 75-Year-Old Patient Has Better Sleep but Insurance Says No
Insurance coverage gaps seniors face often hinder access to effective cannabis care. Many older adults experience improved sleep and reduced medication use with cannabis. However, insurance barriers limit continued treatment despite clinical benefits.
Spontaneous Pneumomediastinum and Cannabinoid Hyperemesis Syndrome: A Case Report and Literature Review
This case report highlights spontaneous pneumomediastinum as a rare complication of cannabinoid hyperemesis syndrome. An 18-year-old chronic cannabis user developed spontaneous pneumomediastinum following severe vomiting. Understanding this complication…
Cannabis Hyperemesis Syndrome: A Psychiatric Approach
Cannabis hyperemesis syndrome psychiatric risk is a critical consideration in patients with chronic cannabis use presenting with cyclical vomiting. This syndrome often poses diagnostic challenges in psychiatric settings due to overlapping symptoms. Early…